Home » Newsletters » BioWorld

BioWorld

Aug. 16, 2010

View Archived Issues

If NIH Challenges Genzyme's Patents, Does Anyone Care?

Telaprevir Looks Ever-Better, But Don't Discount Boceprevir

Money Raised By Biotech in 2010

FDA Approvals in July

Week in Review

Word on the Street

Week in Washington

Phase I Clinical Trials Update: July 2010

Phase II Clinical Trials Update: July 2010

Phase III Clinical Trials Update: July 2010

International AIDS Conference

Non-U.S. Clinical Trials & Regulatory Actions: July 2010

FDA Submissions, Approvals & Other Actions: July 2010

Stock Gainers and Losers For The Week

BioWorld Stock Report For Public Biotechnology Companies

M&A Not Meeting Gangbuster Expectations So Far This Year

At the J.P. Morgan healthcare conference in January, everyone was predicting that 2010 would be a gangbusters year for biotech mergers and acquisitions. Read More

Money Raised Year to Date